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Abstract 
 
Iridium oxide nanoparticles (IrO2 NPs) synthetized following a previously reported chemical route are presented as 
novel tags for immunosensing taking advantage of their electrocatalytic activity towards water oxidation reaction 
(WOR). Cyclic voltammetry and chronoamperometry for the evaluation of the IrO2 NPs electrocatalytic activity towards 
WOR at neutral pH were used. The chronoamperometric current recorded at a fixed potential of +1.3V constituted the 
analytical signal allowing the quantification of IrO2 NPs at nM levels.   Modification of the surface of citrate-capped 
IrO2 NPs with anti-Apolipoprotein E  antibodies (-ApoE) was successfully achieved and the as-prepared conjugates 
were used for the electrocatalytic detection of ApoE Alzheimer disease (AD) biomarker in a magnetosandwich 
immunoassay, reaching a detection limit of 68 ng/mL. Human plasma of a patient suffering AD was also evaluated, 
estimating an ApoE concentration of 20 µg/mL which is in concordance with the obtained in previously reported 
approaches. This novel IrO2 NPs based electrocatalytic assay  presents the advantage of the signal generation in the 
same medium where the immunoassay takes place (PBS, pH 7.4) avoiding the use of additional reagents which also 
opens the way to future integrated biosensing systems and platforms with interest for other proteins as well as DNA and 
cells analysis. 
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1   Introduction 
Recent advances in materials science and, in particular, in the nanomaterials field have opened the way to 
great achievements in immunosensing technology. Outstanding optical and electrochemical properties of 
nanoparticle tags have been extensively studied and applied for immunosensing in the last years, offering 
excellent alternatives to existing conventional strategies/assays with interest in different fields, being the 
early diagnostics based on sensitive detection of protein biomarkers the most relevant one.[1–7]  Of special 
interest is the possibility to electrochemically detect NP tags, due to the inherent advantages of the 
electrochemical techniques in terms of sensitivity, selectivity, low cost and ease of use mode, together with 
the possibility of miniaturization of the detection system.[8–10] NPs such as gold NPs (AuNPs) and quantum 
dots NPs (QDs) have been used as labels for protein biomarkers detection due to their excellent redox 
properties, electrocatalytic activity toward several substrates and easy preparation and bioconjugation 
capabilities.[11,12] However, these approaches often suffer the limitation related to the need of acidic 
solutions either for the total dissolution of the NP tag followed by stripping voltammetric detection[13–16] 
or as source of protons for further electrocatalytic detection based on the hydrogen evolution reaction 
(HER).[17–19]  The use of such acidic solutions, in addition to inherent security risks, represents an 
additional step which not only increases the analysis time but also is a crucial limitation in case of really 
integrated sensing systems, such as those based on lab-on-a-chip or lateral-flow platforms.  Hydrogen 
bubbles formed during hydrogen gas evolution is another inconvenience for the integration of HER based 
biosensing systems in microfluidics platforms. For these reasons, there is a demand for novel NP tags easy 
to be detected in the same medium of the immunoreaction, often saline buffers at neutral pH. In this context 
we consider that NPs able to catalyze water oxidation reaction (WOR) would be ideal candidates for this 
purpose.  
Electrochemical water splitting is composed of two half-cells redox reactions which have been studied 
separately.[20] While the HER proceeds in two-electron process, the evolution of oxygen from water, WOR, 
is a more complex endothermic process (Eº= 1.23 eV at pH 0.0) that involves four electrons and formation 
of an oxygen-oxygen bond. 
2H2O  O2 + 4H+ + 4e-  Eq. 1 
In nature, the photosynthetic water oxidation is catalyzed by a Mn complex in a membrane protein complex 
located in photosynthetic organisms.[21,22] Due to its importance, many studies have been carried out so as 
to understand  the mechanism of water splitting and oxygen formation driven naturally.[23]  Molecular 
complexes based on Ru[24–26], Mn[27,28], Ir[29,30]; bulk metal oxides of Co3O4[31,32],  RuO2 and 
IrO2[33] and moreover, their nanoparticulated metal oxides[34–38] have been studied in the pursuit of a 
synthetic catalyst capable to effectively oxidize water.  In this context, IrO2 is a very attractive material to 
be considered thanks to its catalytic activity, biocompatibility, low resistivity and outstanding chemical and 
thermal stability which has been used for applications in pH sensors[39,40] and neural stimulation.[41,42] 
It is well known that nanomaterials exhibit a large surface area that leads to an increase in their reactivity, 
compared with the bulk material. Due to this property, the catalytic activity of iridium oxide nanoparticles 
(IrO2 NPs, stabilized by citrate ions) towards water oxidation reaction, has been tested under photochemical 
conditions with strong oxidants showing a good catalytic performance.[34,35,43] Citrate capped IrO2  NPs 
showed a remarkable catalytic activity toward the WOR when they were self-assembled on an indium tin 
oxide (ITO) forming an ester layer on the electrode.[36]  
All these noteworthy features make IrO2 NPs ideal candidates for using in biosensing field. However, to the 
best of our knowledge, neither the electrocatalytic activity of IrO2 NPs in suspension nor their use as tags in 
biosensing have not been yet evaluated. Their easy to be measured electrocatalytic properties  at neutral pH 
opens the way to their direct detection in the same medium where the immunoreaction takes place (i.e. PBS 
buffer, pH 7.4), overcoming the above mentioned limitations of other NP-based electrochemical 
immunosensing systems.  
In this work we explore the excellent electrocatalytic property of IrO2 NPs toward WOR and employ this as 
a new signaling route in protein diagnostics. Magnetic beads modified with antibodies are used as platforms 
of the immunoassay which is applied for the detection of Apolipoprotein E (ApoE), a well-established 
biomarker of Alzheimer disease (AD) [44,45]  which is one of the most common cause of dementia. The use 
of this novel label is expected to allow a simpler and user-friendlier methodology for biomarkers detection 
and also to open the way to future integrated biosensing systems and platforms. 
  
2 Experimental 
2.1 Materials and apparatus 
Potassium hexachloroiridate (IV)  (K2IrCl6), sodium hydrogen citrate sesquihydrate (Na2C6H6O7·1.5H2O), 
sodium hydroxide (NaOH); N-(3-Dimethylaminopropyl)-N′-ethylcarbodiimide hydrochloride (EDC), N-
Hydroxysulfosuccinimide sodium salt (sulpho-NHS), phosphate buffer saline in tablet, 2-(N-
morpholino)ethanesulfonic acid (MES buffer), Tween 20, bovine serum albumin (BSA), were purchased 
from Sigma Aldrich. Carboxyl-modified magnetic beads 2.8 µm sized (MBs) were purchased from Dynal 
Biotech. (Dynabeads® M-270, Invitrogen). Capture monoclonal antibody, biotinylated detection mAb, 
streptavidin-enzyme conjugate HRP and purified ApoE as a standard were purchased from Mabtech. mQ 
water, produced using a Milli-Q system (>18.2 Mcm-1) purchased from Millipore, was used for the 
preparation of all solutions. The stirrer used was a TS-100 Thermo shaker (BioSan). A thermostatic 
centrifuge (Sigma 2-16 PK, Fisher Bioblock Scientific) was used to purify the iridium oxide 
nanoparticles/antibody conjugates.  
Human plasma samples of a patient suffering from Alzhemier disease were provided by the Institute of 
Neurology of Ulm University (Germany).  
The electrochemical transducers used were homemade screen-printed carbon electrodes (SPCEs) and the 
measurements were performed using a home-made methacrylate cell connected to an Autolab 20 (Eco-
chemie). See the detailed SPCE fabrication procedure at the Supporting Information. 
2.2  Synthesis and characterization of iridium oxide nanoparticles (IrO2  NPs) 
The procedure for the synthesis of iridium oxide nanoparticles is based on Harriman work.[34] Briefly, 30 
mg of K2IrCl6 were added to 50 mL aqueous solution of 3.8mM sodium hydrogen citrate. The resulting red-
brown solution was adjusted to pH 7.5 using a 0.25 M NaOH solution and then refluxed with constant stirring 
for 30 min. After this, the solution changed its color to a light blue and it was cooled at room temperature 
and the pH of the solution was again adjusted to 7.5. Then, it was stirred and refluxed for 30 min. These 
steps were repeated until obtaining a constant value of pH 7.5. The solution was additionally refluxed for 2 
h with oxygen bubbling through the solution to yield a deep blue suspension of IrO2 NPs (see Figure S2 at 
the Supporting Information). All the experiments were conducted with the as-prepared solution that was 
stored at 4ºC.  
The total amount of iridium in the NPs suspension was obtained by analysis with inductively coupled 
plasma-optical emission spectrometry (ICP-OES) at the Servei d’Anàlisi Química of the Universitat 
Autónoma de Barcelona.  Samples were diluted in aqua regia in a microwave digester (CEM Corporation, 
model MARSXpress) and inserted in the ICP-OES spectrometer (Perkin-Elmer, model Optima 4300DV) to 
obtain the total content of iridium, expressed in mg/L. 
All the sizing measurements and shape characterization of IrO2 NPs were conducted in a Field Emission 
Gun Transmission Electronic Microscope (Fei, model TecnaiTM G2F20). For the sample preparation, 5µL 
of the as-prepared IrO2 NPs dispersion were dropped on a copper grid and let to be dried all the night. 
X-ray photoelectron spectroscopy (XPS) experiments were carried out in the Centres Científics I Tecnològics 
of the Universitat de Barcelona (CCiTUB) and were performed with a PHI 5500 Multitechnique System 
(Physical Electronics) with a monochromatic X-ray source (Aluminium K line of 1486.6 eV energy and 
350 W), placed perpendicularly to the analyzer axis and calibrated using the 3d5/2 line of Ag with a full width 
at half maximum (FWHM) of 0.8 eV.  All measurements were made in an ultra-high vacuum (UHV) 
chamber pressure between 5x10-9 and 2x10-8 torr.  Binding energies were calibrated respect to the C 1s 
electron peak at 284.8 eV.  
2.3 Conjugation of IrO2 NPs to ApoE antibodies  
The ApoE antibodies immobilization on IrO2 NPs was performed by direct random adsorption onto the NP 
surface. Briefly, 100L of 100µg/mL ApoE monoclonal antibody (ApoE mAb) were added to 1.75mL 
of IrO2 NPs suspension adjusted to pH 7. The resulting solution was incubated for 20 min at 650 rpm. Then, 
150L of 5% w/v BSA aqueous solution were added and the stirring was continued for other 20min at 650 
rpm. Finally, the solution was centrifuged at 35000×g (4ºC) for 2 hours and 30 minutes. The supernatant 
was removed and the pellet of iridium oxide NP/ ApoE mAb was re-suspended in 200 µL of milliQ water.  
The same experimental procedure was previously followed for the conjugation of anti-human IgG-
horseradish peroxidase (HIgG-HRP) antibodies to IrO2 NPs so as to check the antibody immobilization on 
the NPs surface. This study was performed by the addition of TMB solution (that acts as HRP substrate) to 
suspensions of IrO2  NPs conjugates at different pH values (pH 7, 8 and 9). Typical change of color from 
colorless to blue was observed when the reaction between the TMB and the HRP labelling the antibodies 
took place, corresponding to the generation of a cation free-radical as oxidation product.  The reaction was 
stopped by adding  H2SO4,  observing a stronger coloration for the conjugates prepared at pH 7 (see figure 
S3 at the Supporting Information), so these conditions were chosen for the preparation of the conjugate 
between IrO2 NPs and the ApoE antibody. 
2.4 Magnetosandwich immunoassay for ApoE capturing and labelling with IrO2  NPs  
Carboxylated magnetic microbeads were functionalized through the well-known EDC/sulfo-NHs chemistry. 
EDC was pre-activated by mixing 133 µL of EDC (10 mg/mL) with 25 µL of sulfo-NHS (100 mg/mL) for 
10 min (both solutions in 100 mM MES, pH 5). After that, 842 µL of 10 mM MES pH 5 were added forming 
solution 1. 15 µL of carboxylated magnetic beads were placed in an Eppendorf tube, washed two times in 
MES buffer and reconstituted in 150 µL of the solution 1. The mixture was incubated at 37 ºC for 30 min 
(700 rpm). Oriented antibody immobilization was performed by adapting a procedure previously optimized 
in our group.[46] Briefly, after washing two times in MES buffer, 30 µL of a 300 µg/mL monoclonal goat 
ApoE antibody solution and 120 µL of 10 mM MES, pH 5, were added to the microspheres and incubated 
at 37 ºC for 1 h (700 rpm). After washing two times in MES buffer, 150 µL of 5 % BSA (in MES buffer) 
were added to the microspheres and incubated first at 25 ºC for 20 min (700 rpm) and then at 4 ºC overnight.  
After washing two times in PBS-Tween buffer and once in PBS buffer, 150 µL of recombinant ApoE 
standard in PBS buffer was added to the microspheres and incubated at 25 ºC for 20 min (700 rpm). After 
washing two times in PBS-Tween buffer and once in PBS buffer, 150 µL of the previously synthesized IrO2  
NPs/ ApoE antibody were added to the microspheres and incubated at 25 ºC for 20 min (700 rpm). The 
magnetic conjugate was washed four times in PBS-Tween 20 buffer, two times in PBS, once in water and 
reconstituted in 150 µL of 0.1 M PBS. 
In the case of the analysis of human plasma samples, the same experimental procedure was followed, using 
serial diluted plasma samples in PBS buffer instead of the standard of ApoE. 
2.5 Electrochemical measurements 
Each electrochemical measurement was performed after dropping 50 µL of IrO2 NPs suspension in 0.1M 
PBS pH 7.4 freshly prepared onto the SPCE.  Blank signals were recorded following the same 
electrochemical procedure but using an aliquot of buffer. Cyclic voltammetry (CV) was carried out from -
0.5 V to +1.3 V at 50 mV s−1 and chronoamperometry was performed at a fixed potential of +1.3V during 
300 s. 
The electrochemical detection of ApoE captured through the magnetosandwich immunoassay was evaluated 
through the water oxidation reaction. Briefly, 50 μL of the immunocomplex suspension were placed on the 
surface of the screen-printed carbon electrode (SPCE), where a magnet was previously attached to polyester 
on the reverse side of the working area. An oxidative potential of +1.3 V was applied during 300s. The water 
oxidation catalyzed by the IrO2 NPs tags was chronoamperometrically followed measuring the current 
generated during the time. The absolute value of the current at 250 s was chosen as the analytical signal. For 
all the experiments, the measurements were made by triplicate at room temperature.  
 
3 Results and discussion 
3.1 Characterization of  IrO2  NPs  
Characterization of IrO2 NPs was conducted through different techniques as UV-visible spectrophotometry 
(UV-Vis), transmission electronic microscopy (TEM) and X-ray photoelectron spectroscopy (XPS). 
Hydrolysis of hexachloroiridate (IV) ion, [IrCl6]2-, in neutral aqueous solutions in the presence of citrate 
ions, results in formation of deep blue suspension of nanoparticles of IrO2.xH2O[34] (for simplicity, they 
will be denoted as IrO2). TEM micrographs reveal the homogeneous distribution of IrO2 NPs (see Figure 1) 
and is worthy to note the homogeneous size of observed agglomerates of 12.5±2.5 nm composed by smaller 
nanoparticles of 1.5±0.3 nm. This suggests that the initially formed small nanoparticles quickly form bigger 
agglomerates. This behavior is in agreement with previously  reported studies.[35,47]  
UV-Vis spectrum of IrO2 NPs is shown in Figure 1B, where  a broad peak between 500-700nm with  
maximum at 590 nm, characteristic of  Ir(IV) oxides and IrO2 NPs is observed.[34] 
XPS analyses were performed in order to confirm the chemical composition of the synthesized IrO2 NPs 
(see Figure 1C, left). By deconvoluting the XPS spectra, two binding states for iridium are identified as 4f7/2 
and 4f5/2 at 62.3 and 65.1 eV, respectively. These peaks are attributed to the 4+ oxidation state of iridium 
and they are similar to those of IrO2 nanorods (62.0 and 65.0 eV) and similar to IrO2 single crystal (which 
has values of 61.7 and 64.7 eV).[48]  Regarding the oxygen 1s signal, a main peak at 531.6 and a small one 
at 533.7 eV were observed as shown in figure 1C (right). The former is similar to the value found for IrO2 
nanorods and IrO2 single crystal, both at 530.5eV.[48] The broader feature at 533.7 eV might be attributed 
to the oxygen-containing citrate coating these nanoparticles.  
According to the mentioned characterization, especially with the XPS analyses, it is possible to conclude 
that the deep-blue suspension synthetized corresponds to IrO2 nanoparticles. 
The concentration of iridium oxide stock solution was calculated to be around 35 nM using the concentration 
of Ir obtained by ICP-OES (0.227 mg/mL; 1.18 mM) divided by the number of atoms per particle (N) as 
stated in Supporting Information. 
3.2 Electrocatalytic activity of IrO2  NPs towards WOR 
The electrocatalytic activity of IrO2 NPs towards water oxidation reaction was first evaluated by cyclic 
voltammetry (CV) using screen-printed carbon electrodes (SPCE). 
CV voltammograms were conducted in 0.1M PBS pH 7.4 and obtained by scanning from +0.1 to +1.3 V at 
50mV/s scan rate. The as-performed voltammograms for different concentrations of IrO2 NPs in 0.1 MPBS 
are shown in figure 2A. The background curve (a) shows that the oxidation of the medium’s oxygen starts 
at approximately +1.10V. In the presence of the IrO2  NPs (curves b-e) on the surface of the electrode, the 
potential for water oxidation shifts (by up to 300 mV, depending on the concentration of IrO2 NPs) toward 
less positive potentials. Moreover, it can also be seen that, because of the catalytic effect of the IrO2 NPs, a 
higher current is generated (up to 70 μA higher, as evaluated for the potential value of +1.3 V, depending on 
the concentration of IrO2 NPs). A shift in the half-wave potential of the WOR to less positive potentials from 
1.1V to up to 0.77 V (maximum shift of 332 mV) which is proportional to the quantity of IrO2  NPs due to 
their catalytic effect towards this reaction can also be observed in the same figure. 
The obtained results show that, for a fixed potential (i.e., +1.3 V at which steady state currents values are 
achieved), the intensity of the current recorded in chronoamperometric mode during the stage of oxygen 
electro-oxidation (Figure 2B) can be related to the presence (curves b’-e’) or absence (curve a’) of IrO2 NPs 
on the surface of the SPCE. A proportional increase of the catalytic current for increasing concentrations of 
IrO2 NPs (from 0.7 to 35 nM) was observed.  
Regarding the fixed interval of time selected for the current recording (analytical signal), it was observed 
that for intervals shorter than 250 s the current profiles were not reproducible. Looking at the behavior during 
the first 50 s, a rapid decrease in the anodic current was observed, probably due to an initial rapid oxidation 
of water on the surface of the IrO2 NPs catalyzers followed by a current stabilization. This effect is more 
evident for higher IrO2 NPs concentrations (curves d’ and e’). The observed irreproducibility during the 50‐
250 s range could be attributed to the fact that IrO2 NPs are still not accommodated onto the electrode surface 
being still under Brownian motions (stabilization time). The current value was stable in all cases after 250 
s, so registering at this time interval was chosen as analytical signal.  
A logarithmic relationship between the analytical signal and the concentration of IrO2 NPs in the range of 
0.7-35 nM adjusted  to the following equation: 
Current (µA) = 3.15 ln[IrO2 NPs] + 8.13 Eq. 2 
showing a good correlation (r=0.98) and a relative standard deviation  of 5.6% for 7nM of IrO2 NPs (n=3). 
The limit of detection was calculated as the concentration of IrO2 NPs corresponding to three times the 
standard deviation of the estimated, giving a value of 0.13nM. 
 
3.3 Electrocatalytic  detection of ApoE Alzheimer disease biomarker in human plasma  
Magnetic beads were used as platforms of the immunoassays for ApoE detection, taking advantage of their 
well-known characteristics for capturing/pre-concentrating the analyte and minimizing matrix effects. 
Carboxylated magnetic beads were modified with ApoE antibody using the EDC-sulpho-NHS coupling. 
First, EDC was used in order to activate the carboxylic groups located on the surface of magnetic beads. 
Then, addition of sulpho-NHS led to formation of a stable sulpho-ester, which reacts with the amine groups 
located in the antibody, allowing forming of  the  ApoE modified magnetic beads (ApoE-MB). Blocking 
with BSA is performed in order to avoid unspecific absorptions onto the surface of the electrotransducer. 
When  ApoE is present in the sample, it is recognized by the ApoE antibody forming the ApoE/ApoE-
MB complex.  
Once the washing step is performed, the conjugate of ApoE-IrO2 NPs is able to recognize the ApoE , 
forming the magnetosandwich ApoE-IrO2 NPs /ApoE/ApoE-MB, being the amount of IrO2 NPs  
proportional to the ApoE concentration in the sample.  
Electrochemical detection of ApoE was carried out using 50 μL of the immunocomplex suspension placed 
onto the surface of the SPCE and taking advantage of the electrocatalytic properties of IrO2  NPs towards 
WOR. The catalytic behavior of the IrO2 NPs generated by the oxidation of water is conducted by 
chronoamperometry and correlated to the amount of the ApoE in the sample. Figure 4A shows the 
chronoamperograms obtained for samples containing 0 (a) , 100 (b), 200 (c), 500 (d) and 1000 (e)  ng/mL 
of ApoE. As expected, the catalytic current increases when the concentration of ApoE increases. The 
relationship between the concentration of ApoE in the sample and the value of the analytical signal (current 
recorded at 250s) is adjusted to a logarithmic curve, as shown in Figure 4B. The curve exhibits a good 
correlation (r= 0.98) in the range of 100-1000 ng/mL, adjusted to the following equation:  
Current (µA)= 2.64 [ApoE (ng/mL)] – 10.94 Eq. 3 
The limit of detection, calculated as stated before, gives a value of 68 ng/mL.  The reproducibility of the 
responses (n=3) for 500ng/mL of ApoE shows a relative standard deviation of 6%. 
Finally, a human plasma sample with an unknown concentration of ApoE was electrocatalytically analyzed. 
As ApoE concentration in plasma typically ranges from 16 to 169 μg/mL,[49] very small volumes of plasma 
were diluted in PBS buffer before analysis.  A dilution of the sample of 1:1000 was necessary to obtain a 
current within the linear range of the method, obtaining a value of 3.08 ± 0.18 µA (n=3)  for such a dilution. 
Extrapolating this value from Eq. 3, a concentration of ApoE of 20 ± 2 µg/mL was estimated in the sample. 
Matrix effects are not relevant in our assay due to two main factors. First of all, possible interfering 
substances are highly diluted in the analyzed sample (1:1000). Furthermore, and more importantly, the use 
of magnetic bead platforms modified with an specific antibody allow us to capture the ApoE protein and 
then separate the magnetic bead/ApoE complex from the matrix of the sample, thanks to the use of a 
magnetic field. Magnetic beads are conveniently blocked before with BSA so as to avoid unspecific 
absorptions. The final measurements are performed in PBS buffer, so not background contributions are 
neither found at the +1.3V voltage applied. 
The obtained results are in concordance with the above mentioned expected data and also with those 
previously obtained in our group using both microarray technology[50]  and electrochemical detection[51] 
based on commercial Quantum Dot tags.   
4 Conclusions 
Iridium oxide nanoparticles (IrO2 NPs) of 12 nm size were successfully synthesized, characterized and used 
as novel electrocatalytic tags for immunosensing.  The stable NPs suspension exhibited a high catalytic effect 
towards the Water Oxidation Reaction (WOR), allowing their sensitive quantification at neutral pH in a 
simple chroroamperometric mode. This sensitive method was applied for the evaluation of ApoE in human 
plasma following an immunoassay format using IrO2 NPs as advantageous tags, able to be detected in the 
same buffer where the immunoreaction takes place.   
Both the IrO2 NPs tags and electrocatalytic detection method present many advantages compared with 
previously reported ones based on quantum dots (QDs) or Hydrogen Evolution Reaction (HER) . On the one 
hand, the NP synthesis procedure is simpler and cheaper than i.e. the required for QDs preparation. 
Furthermore, the chronoamperometric detection based on the WOR is a simple, sensitive and quantitative 
methodology that can be performed in the same medium of the immunoreaction, avoiding the addition of 
acidic and hazardous solutions, (along with H2 bubbles formation undesired in microfluidics), usually 
required for electrochemical detection of other NP tags (ex. AuNP using HER). These advantageous 
properties open the way to further applications in really integrated sensing systems, such as those based on 
lab-on-a-chip or lateral-flow platforms. Moreover, the UV-Vis absorption band observed at 590 nm (deep 
blue color) of the  IrO2 NPs suspension make these NPs excellent candidates for dual electrochemical/optical 
detection systems in future lateral flow biodetection platforms. 
This novel methodology can be extended for the detection of other AD biomarkers (i.e. -amyloid) 
representing a simple, rapid and sensitive alternative for AD diagnostics. Furthermore, it opens the way to 
future integrated biosensing systems and platforms with interest for other proteins as well as DNA and cells 
analysis. 
 
 
  
 Acknowledgements 
We acknowledge the support from MINECO (Spain) under project MAT2011-25870, the E.U. under FP7 
contract no. 246513 “NADINE”. Prod. Dr. Markus Otto from the Institute of Neurology of Ulm University 
(Germany) is also acknowledged for kindly providing the human serum samples of a patient suffering from 
Alzheimer disease.  
References 
[1]  A. de la Escosura-Muñiz, C. Parolo, A.  Merkoçi, Mater. Today  2010, 13, 24. 
[2]  L. Dykman, N. Khlebtsov, Chem. Soc. Rev. 2012, 41, 2256. 
[3]  E. C. Dreaden, A. M.  Alkilany, X.  Huang, C. J.  Murphy, M. A. El-Sayed, Chem. Soc. Rev. 
2012, 41, 2740. 
[4]  A. Walcarius, S. D.  Minteer, J. Wang, Y. Lin, A. Merkoçi, J. Mater. Chem. B 2013, 1, 4878. 
[5]  A. Ambrosi, M. T. Castañeda, A.  de la Escosura-Muñiz, A. Merkoçi, in Biosensing using 
nanomaterials-Bionano (Ed.:  A. Merkoçi), Wiley-Interscience, New York, 2009, pp. 177–197. 
[6]  A. Merkoci, A. Ambrosi, A. de la Escosura, B.  Pérez, M.  Guix, M.  Maltez, S.  Marin, in 
Encyclopedia of Analytical Chemistry, (Ed.: R. A. Meyers), John Wiley, Chichester, 2010, pp. 
1-26 
[7]  A. Merkoci, Biosensensors Bioelectron. 2010, 26, 1164. 
[8]  A. de la Escosura-Muñiz,  A.  Ambrosi,  A.  Merkoçi, Trends Anal. Chem. 2008, 27, 568. 
[9]  A. Merkoçi, Electroanalysis 2013, 25, 15. 
[10]  A. Merkoçi, FEBS J. 2007, 274, 310. 
[11]   A. de la Escosura-Muñiz, A. Merkoçi, Expert Opin. Med. Diagn. 2010, 4, 21. 
[12]  D. Tang, Y. Cui, G.  Chen, Analyst 2013, 138, 981. 
[13]  M. Dequaire, C. Degrand, B. Limoges, Anal. Chem. 2000, 72, 5521. 
[14]  N. Zhu, A. Zhang, Q. Wang, P. He, Y. Fang, Electroanalysis 2004, 16, 577. 
[15]  R. Cui, H. C.  Pan,  J. J.  Zhu, H. Y. Chen, Anal. Chem. 2007, 79, 8494. 
[16]  J. Wang, G. Li, A.  Merkoçi, J. Am. Chem. Soc. 2003, 125, 3214. 
[17]  M. T. Castañeda, S.  Alegret, A.  Merkoçi, Electroanalysis 2007, 19, 743. 
[18]  A. Ambrosi, M. T. Castañeda, A. J. Killard, M. R. Smyth, S. Alegret, A. Merkoçi, Anal. Chem. 
2007, 79, 5232. 
[19]  A. de la Escosura-Muñiz, C. Sánchez-Espinel, B. Díaz-Freitas, A. González-Fernández, M. 
Maltez-Da Costa, A. Merkoçi, Anal. Chem. 2009, 81, 10268. 
[20]  H. Dau, C.  Limberg, T. Reier, M.  Risch, S. Roggan, P. Strasser, ChemCatChem 2010, 2, 724. 
[21]  T. J. Meyer, Nature 2008, 451, 778. 
[22]  Y. Umena, K. Kawakami, J. R.  Shen, N. Kamiya, Nature 2011, 473, 55. 
[23]  K. S. Joya, Y. F. Joya, K. Ocakoglu, R. van de Krol, Angew. Chemie, Int. Ed. 2013, 52, 10426. 
[24]  C. Sens, I. Romero, M.  Rodríguez, A. Llobet, T. Parella, J. Benet-Buchholz, J. Am. Chem. Soc. 
2004, 126, 7798. 
[25]  S. Romain, L. Vigara, A. Llobet, Acc. Chem. Res. 2009, 42, 1944. 
[26]  L. Duan, F.  Bozoglian, S.  Mandal, B.  Stewart, T.  Privalov, A. Llobet, L. Sun,  Nat. Chem. 
2012, 4, 418. 
[27]  P. Kurz, G. Berggren, M. F. Anderlund, S. Styring , Dalt. Trans. 2007, 4258. 
[28]  E. A. Karlsson, B.  L.  Lee, T. Akerman, E.  Jhonston, M. Kärkäs, J. Sun, Ö. Hannson, J. E. 
Bäckwall, B. Akerman,  Angew. Chemie 2011, 123, 11919. 
[29]  N. D. McDaniel, F. J.  Coughlin, L. L. Tinker, S.  Bernhard,  J. Am. Chem. Soc. 2008, 130, 210. 
[30]  H. Junge, N.  Marquet, A. Kammer, S. Denurra, M. Bauer, S.  Wohlrab, F. Gärtner, M.  Pohl, 
A. Spannenberg, S. Gladiali, M. Beller, Chemistry 2012, 18, 12749. 
[31]  A. Harriman, I. J. Pickering, J. M.  Thomas, P. A. Christensen, J. Chem. Soc. Faraday Trans. I 
1988, 84, 2795. 
[32]  R. N. Singh, D. Mishra, A. S. K. Anindita, A. Singh, Electrochem. commun. 2007, 9, 1369. 
[33]  S. Trasatti, J. Electroanal. Chem. Interfacial Electrochem. 1980, 111, 125. 
[34]  A. Harriman, J. M.  Thomas, New J. Chem. 1987, 11, 757. 
[35]  M. Hara, T. E.  Mallouk, Chem. Commun. 2000, 1903. 
[36]  M. Yagi, E. Tomita, S. Sakita, T. Kuwabara, K. Nagai, J. Phys. Chem. B 2005, 109, 21489. 
[37]  Y. Zhao, E. A.  Hernandez-Pagan, N. M. Vargas-Barbosa, J. L.  Dysart, T. E. Mallouk, J. Phys. 
Chem. Lett. 2011, 402. 
[38]  Y. Lee, J. Suntivich, K. J. May, E. E.  Perry, Y.  Shao-horn, J. Phys. Chem. Lett. 2012, 3, 399. 
[39]  D. O’Hare, K. H. Parker, C. P. Winlove, Med. Eng. Phys. 2006, 28, 982. 
[40]  W. D. Huang,  H. Cao, S. Deb, M. Chiao, J. C. Chiao, Sensors Actuators A 2011, 169, 1. 
[41]  Y.  Lu, T.  Wang, Z. Cai, Y. Cao, H. Yang, Y. Y. Duan, Sensors Actuators B Chem. 2009, 137, 
334. 
[42]  K. Göbbels, T. Kuenzel, A. van Ooyen, W. Baumgartner, U. Schnakenberg, P.  Bräunig, 
Biomaterials 2010, 31, 1055. 
[43]  M. Hara, C. C. Waraksa, J. T.  Lean, B. A. Lewis, T. E.  Mallouk, J. Phys. Chem. A 2000, 104, 
5275. 
[44]  J. Kim, J. M. Basak, D. M. Holtzman, Neuron 2011, 63, 287. 
[45]  I. Reinvang, T. Espeseth, L. T. Westlye, Neurosci. Biobehav. Rev. 2013, 37, 1322. 
[46]  C. Parolo, A. de la Escosura-Muñiz, E. Polo, V. Grazu, J. De La Fuente, A. Merkoçi, ACS Appl. 
Mater. Interfaces 2013, 5, 10753. 
[47]  S. J. Kwon, F. R. Fan, A. J. Bard, J. Am. Chem. Soc. 2010, 132, 13165. 
[48]  R. S. Chen, Y. Huang, Y. M. Liang, D. S. Tsai, Y.  Chi, J. J. Kai, J. Mater. Chem. 2003, 13, 
2525. 
[49]  M. Vicent-Viry, F. Schiele, R. Gueguen, K. Bohnet, S. Visvikis, Clin. Chem. 1998, 44, 957. 
[50]  E. Moralez-Narváez, H.  Montón, A. Fomicheva, A. Merkoçi, Anal. Chem. 2012, 84, 6821. 
[51]  M. Medina-Sánchez, S.  Miserere, E. Moralez-Narváez, A. Merkoçi, Biosens. Bioelectron. 2014, 
54, 279.  
 
  
 
Fig. 1. Characterization of IrO2 NPs. (A) TEM micrographs, (B) UV-Vis spectrum, (C) XPS analysis: spectrum for Ir 
4f line (left)  and O 1s line (right). 
  
 
 
Fig. 2. Electrocatalytic activity of IrO2 NPs towards WOR. (A)  Cyclic voltammograms recorded from +0.1 to +1.3 V 
at a scan rate of 50 mV/s for  0.1 M PBS (blank curve, a) and for increasing concentrations of IrO2 NPs in 0.1 M PBS 
pH 7.4: (b) 0.7, (c) 1.8, (d) 7 and (e) 35 mM. (B) Chronoamperograms recorded at +1.3V during 300 s using a 0.1 M 
PBS pH 7.4  (blank curve, a) and the same IrO2 NPs concentrations as detailed above (b’-e’) in 0.1M PBS. 
  
 
Fig. 3. Schematics, not in scale, of: (A) experimental procedure of the magnetosandwich immunoassay using IrO2 NPs 
tags and (B) electrochemical detection procedure based on the electrocatalytic water oxidation. 
  
Fig. 4. (A) Chronoamperograms recorded in PBS 0.1M pH 7.4 at a fixed potential of +1.3V, for a control sample (blank 
curve, a) and for samples containing 100 (b) , 200 (c), 500 (d) and 1000 (e)  ng/mL of ApoE. (B) Relationship between 
the  ApoE concentration and the value of the analytical signal (catalytic current recorded at 250s). Samples correspond 
to the magnetosandwich prepared as detailed in the experimental section. 
 
 
